HB
DGX icon

Homrich & Berg’s Quest Diagnostics DGX Stock Holding History

Homrich & Berg’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-6,961
Closed -$640K – 301
2016
Q4 		$640K Buy
6,961
+281
+4% +$24.2K 0.06% 131
2016
Q3 		$565K Buy
6,680
+407
+6% +$34.2K 0.05% 138
2016
Q2 		$511K Buy
6,273
+79
+1% +$6.02K 0.05% 137
2016
Q1 		$443K Buy
6,194
+322
+5% +$21.6K 0.04% 155
2015
Q4 		$418K Buy
+5,872
New +$395K 0.04% 165

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Homrich & Berg's DGX Position: Q1 2017 in Review

Homrich & Berg sold out of Quest Diagnostics (DGX) in Q1 2017, closing a stake of 6,961 shares — an estimated $640K sold.

Homrich & Berg first reported a position in DGX in Q4 2015 and held it in 5 quarters. The position peaked at $640K in Q4 2016. 614 funds tracked by Wall St. Rank hold DGX as of Q1 2017.

  • Homrich & Berg reported no remaining Quest Diagnostics position as of Q1 2017 after selling out during the quarter.
  • Homrich & Berg sold 6,961 Quest Diagnostics shares in Q1 2017, an estimated $640K.
  • Homrich & Berg first reported a position in Quest Diagnostics in Q4 2015 and held it in 5 quarters.
  • Homrich & Berg's Quest Diagnostics position peaked at $640K in Q4 2016.
  • 614 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2017.

Based on Homrich & Berg's 13F filing for Q1 2017, filed 11 May 2017.